Mar 1, 2026 Log in

財報

Nang Kwong Chemo-Pharmaceutical Co., Ltd.: Q1 2026 EPS 0.32 NTD

Citation-Grade Primary-source linked Schema.org verified NQ 0 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published Mar 1, 2026 9:00 AM ・ Updated May 16, 2026 1:34 PM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

Nang Kwong Chemo-Pharmaceutical Co., Ltd.
(Stock Code: 1752) announced its Q1 2026 financial results, reporting an EPS of 0.32 NTD, operating revenue of 530 million NTD, and net profit of 32 million NTD, indicating steady performance in the biotechnology and medical sector.

Nang Kwong Chemo-Pharmaceutical Co., Ltd. (Stock Code: 1752) announced its Q1 2026 financial results, reporting an EPS of 0.32 NTD, operating revenue of 530 million NTD, and net profit of 32 million NTD, indicating steady performance in the biotechnology and medical sector.

PRIMARY SOURCE Original source: https://openapi.twse.com.tw/financial/twse-fin-1752-2026Q1 Distributor: PR Times
Published: Mar 1, 2026

Company Code: 1752 Company Name: Nang Kwong Chemo-Pharmaceutical Co., Ltd. Industry: Biotechnology and Medical Period: 2026 Q1 Basic Earnings Per Share: 0.32 NTD Operating Revenue: 530 million NTD Net Profit After Tax: 32 million NTD

FACT BOX

Source: PR Times
Category: 財報

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　Mar 1, 2026 9:00 AM — Distributor PR Times
Collected　May 9, 2026 8:00 AM
AI structured & analyzed　May 9, 2026 8:34 AM
Desk-reviewed & published　Mar 1, 2026 9:00 AM

FAQ

What are the key facts in this article?

Where is the primary source?

PR Times: https://openapi.twse.com.tw/financial/twse-fin-1752-2026Q1

When was it published?

Mar 1, 2026

Cite this article — HOW TO CITE

Washin AI News Desk“Nang Kwong Chemo-Pharmaceutical Co., Ltd.: Q1 2026 EPS 0.32 NTD”AI News by Washin Village（和心村）, Mar 1, 2026. https://aeo.washinmura.jp/ai/%E5%8D%97%E5%85%89%E5%8C%96%E5%AD%B8%E8%A3%BD%E8%97%A5%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8/en/news/2026-03-01-nan-kuang-pharmaceutical-co-ltd-2026-q1

AI CRAWLER ACTIVITY

as of Jul 17, 2026

AI crawler visits to this article (cumulative)153 bots

Site-wide cumulative

Applebot

bot_visits_summary

4129k

last Jul 17, 2026

ClaudeBot

bot_visits_summary

3019k

last Jul 17, 2026

GPTBot

bot_visits_summary

2582k

last Jul 17, 2026

Bingbot

bot_visits_summary

2448k

last Jul 17, 2026

Meta AI

bot_visits_summary

1010k

last Jul 17, 2026

Google AI

bot_visits_summary

687k

last Jul 17, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 南光化學製藥股份有限公司 Back to newsroom (13)

Copied